bioMérieux Sponsored Session: Comprehensive Clinical Solution Throughout the Acute Care Patient Journey
Description:
Date/Time: September 25, 2024 | 1:25 - 1:55 pm ET
In this sponsored session, attendees will learn how a comprehensive diagnostic portfolio including molecular, immunoassay, and microbiology solutions can support sepsis patient outcomes. The presenter will describe how laboratory diagnostics can lead to optimized therapy for patients suffering from sepsis. After the presentation, attendees will be able to design a strategy to optimize the use of rapid diagnostics upon implementation and will have a better understanding of the impact of sepsis.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Daniel Feinstein, MD, MS, FACP, ACRP-PI
Director of Pulmonary Critical Care Medicine
Novant Healthcare
Daniel Feinstein, MD, MS, FACP, ACRP-PI, is the Director of Pulmonary Critical Care Medicine and MSICU at Moses Cone Hospital in Greensboro, NC. He is a Clinical Assistant Professor at University of North Carolina Medical School. He completed his fellowship in Critical Care Medicine at Rush Medical Center in Chicago. Dr. Feinstein is board certified in Critical Care Medicine and has been practicing Critical Care Medicine for 17 years. He has done extensive research in a multitude of trials for sepsis, shock, antibiotic stewardship, and novel antibiotics.
Summit 2024 Session: bioMérieux Sponsored Session: Comprehensive Clinical Solution Throughout the Acute Care Patient Journey
Session Day/Time: Wednesday, September 25, 2024, 1:25 PM - 1:55 PM EST